{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:37:42Z","timestamp":1760661462141,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jdcr.2025.03.033","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T21:02:07Z","timestamp":1746738127000},"page":"18-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neutrophilic eccrine hidradenitis following dasatinib initiation in a patient with chronic myeloid leukemia"],"prefix":"10.1016","volume":"61","author":[{"given":"Avery","family":"Watson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Noble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Badon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Cruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jdcr.2025.03.033_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jaad.2017.11.064","article-title":"Neutrophilic dermatoses: pathogenesis, sweet syndrome, neutrophilic eccrine hidradenitis, and beh\u00e7et disease","volume":"79","author":"Nelson","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.03.033_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000356229","article-title":"A classic clinical case: neutrophilic eccrine hidradenitis","volume":"5","author":"Copaescu","year":"2013","journal-title":"Case Rep Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.03.033_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ccr3.1932","article-title":"Neutrophilic eccrine hidradenitis secondary to pegfilgrastim in a patient with synovial sarcoma","volume":"7","author":"Puar","year":"2019","journal-title":"Clin case Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2025.03.033_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/0008-5472.CAN-05-2050","article-title":"Dasatinib (BMS-354825), a dual SRC\/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies","volume":"66","author":"Schittenhelm","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jdcr.2025.03.033_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-4632.2006.02606.x","article-title":"Neutrophilic eccrine hidradenitis in non-small cell lung cancer","volume":"46","author":"Lee","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdcr.2025.03.033_bib6","series-title":"StatPearls [Internet]","article-title":"Neutrophilic Eccrine Hidradenitis","author":"Crane","year":"2023"},{"issue":"1","key":"10.1016\/j.jdcr.2025.03.033_bib8","first-page":"19","article-title":"Cutaneous complications of molecular targeted therapy used in oncology","volume":"9","author":"Lupu","year":"2016","journal-title":"J Med Life"},{"key":"10.1016\/j.jdcr.2025.03.033_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management","volume":"8","author":"Shyam Sunder","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.jdcr.2025.03.033_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0190-9622(96)90092-4","article-title":"Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis","volume":"35","author":"Shear","year":"1996","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625001699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625001699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:55:18Z","timestamp":1760644518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625001699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":9,"alternative-id":["S2352512625001699"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.03.033","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophilic eccrine hidradenitis following dasatinib initiation in a patient with chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}